Category: Life Sciences
North America Life Sciences
-
Marijuana Stores
... dominate the industry. COMPETITIVE LANDSCAPE Demand is driven by demographics, public awareness of the marijuana plant's medicinal properties, and the desire for natural health treatments. Following decades of prohibition in the US, marijuana has gained ... Read More
-
Medical Equipment & Supply Wholesalers
... Patterson Companies (all based in the US), along with EBOS Group (Australia), OneMed (Sweden), and Yamashita Medical Instruments (Japan). COMPETITIVE LANDSCAPE Pressure to control health care expenditures is intensifying price negotiations for wholesalers and prompting ... Read More
-
Home Health Care Services
... Amedisys, Apria, CenterWell Home Health, and Lincare (all based in the US), along with Cera Care (UK), LVL Médical (France), and SE Health (Canada). COMPETITIVE LANDSCAPE Health reform efforts are driving down reimbursement for medical ... Read More
-
Physicians
... improving quality of care. The profitability of individual practices depends on the reputation, cost, operational efficiencies, and expertise of the physician and staff. Large practices have advantages in leveraging administrative processes and expensive diagnostic equipment. ... Read More
-
Clinical Rollators
... CAGR of 5.0% over the analysis period 2024-2030. 4-Wheeler Rollators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$262.0 Million by the end of the analysis ... Read More
-
Counter Cyber Terrorism
... at a CAGR of 2.8% over the analysis period 2024-2030. Firewall, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$19.1 Billion by the end of the ... Read More
-
Flavored Syrups
... CAGR of 4.4% over the analysis period 2024-2030. Beverages, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$25.5 Billion by the end of the analysis period. ... Read More
-
Garden Tools
... CAGR of 4.9% over the analysis period 2024-2030. Pruning Tools, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$50.8 Billion by the end of the analysis ... Read More
-
Swine Health
... CAGR of 5.8% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. ... Read More
-
Vision Care
... CAGR of 2.3% over the analysis period 2024-2030. Glass Lens, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$54.6 Billion by the end of the analysis ... Read More
-
Dental Diagnostic Imaging Equipment
... 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Intraoral Imaging Systems, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$3.3 Billion by ... Read More
-
Spring and Wire Products
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$47.0 Billion by the end ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion by ... Read More
-
Vancomycin
... 4.9% over the analysis period 2024-2030. Lung Infection, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. Growth ... Read More
-
Internet Ad Spending
... at a CAGR of 7.8% over the analysis period 2024-2030. Search, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$214.9 Billion by the end of the ... Read More
-
Long-Term Care
... CAGR of 5.5% over the analysis period 2024-2030. Public Payer, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Trillion by the end of the analysis ... Read More
-
Hepatitis B Vaccines
... at a CAGR of 4.3% over the analysis period 2024-2030. Adult, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.7 Billion by the end of the ... Read More
-
Intrauterine Devices
... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Krill Oil
... CAGR of 10.1% over the analysis period 2024-2030. Softgels, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$485.1 Million by the end of the analysis period. ... Read More
-
Online Home Rental Services
... 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Flats, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$40.3 Billion by the end ... Read More
-
Sleeping Aids
... CAGR of 5.3% over the analysis period 2024-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$36.9 Billion by the end of the ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion ... Read More
-
Artificial Insemination
... CAGR of 7.2% over the analysis period 2024-2030. Intrauterine, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis period. ... Read More
-
Home Care Services
... at a CAGR of 7.3% over the analysis period 2024-2030. Maid Services, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.7 Billion by the end of ... Read More
Research Assistance
